Trademark Search / LIQUID BIOPSY IS REVOLUTIONIZING CANCER TREATMENT. NRICHDX EMPOWERS THAT REVOLUTION.
LIQUID BIOPSY IS REVOLUTIONIZING CANCER TREATMENT. NRICHDX EMPOWERS THAT REVOLUTION.
● Live · RegisteredU.S. federal trademark · Serial No. 88250571 · Reg. No. 6190469
Mark
LIQUID BIOPSY IS REVOLUTIONIZING CANCER TREATMENT. NRICHDX EMPOWERS THAT REVOLUTION.
Filing Date
January 4, 2019
Registration Date
November 3, 2020
Goods & Services
cell culture and cancer diagnostics tests, namely, liquid biopsy testing systems consisting of a specimen chamber assembly and magnetic materials used to sequester target analytes of interest within a liquid sample for isolation and characterization
Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "LIQUID BIOPSY IS REVOLUTIONIZING CANCER TREATMENT. NRICHDX EMPOWERS THAT REVOLUTION." or anything like it, before you file.
Run a free trademark search →Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.